Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-08
Pages: 172 Pages
Report ld: 4945242
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Organ On Chip Market Size(US$)
CAGR 2025-2031
30.2%
Market Size,2031
USD 1,076
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 221 million
Market Forecast in 2031(Value)
US$ 1,076 million
CAGR
30.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Organ On Chip market is projected to grow from US$ 166 million in 2024 to US$ 1076 million by 2031, at a CAGR of 30.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.
The organ-on-a-chip market is primarily driven by the growing demand for more efficient, accurate, and ethically compliant in vitro biological models. Traditional drug development methods are often costly, time-consuming, and have low clinical translation success rates. In contrast, organ-on-a-chip technology, which closely mimics the microenvironment and functions of human organs, offers a promising alternative to improve drug screening efficiency and predictive accuracy. Increasing restrictions on animal testing, especially in regions like North America and Europe, are also accelerating the adoption of advanced alternatives that align with the "3Rs" principle—Replacement, Reduction, and Refinement—making organ-on-a-chip an ethically favorable solution. Furthermore, the rise of personalized and precision medicine is driving the use of patient-derived cells in organ chips for individualized drug testing and response prediction. Technological advancements across regenerative medicine, immunotherapy, and bioengineering are supporting the diversification and platformization of organ chip systems. In addition, sustained investment from both the public and private sectors in biotechnology is facilitating the commercialization of organ-on-a-chip platforms. As multi-organ chips evolve and integrate with AI, biosensors, and other digital health technologies, the market is expected to see rapid growth across high-value applications such as drug discovery, toxicity testing, and disease modeling.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Organ On Chip market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by End User, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Emulate
- Mimetas
- TissUse
- Valo Health
- CN Bio Innovations
- Hesperos
- Draper Laboratory
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
- Altis Biosystems
- Bi/ond
- Netri
- Xona Microfluidics
- SynVivo, Inc.
- Beijing Daxiang Biotech
- AVATARGET
- Suzhou Jiyan Biopharmaceutical
- InSphero
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Vessel-on-a-chip
- Other Organs
Segment by Application
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Cosmetics Industry
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Organ On Chip study scope, segments the market by Type and by End User, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by End User, identifies emerging use cases, and profiles leading customers by region and by End User.
Chapter 6: North America—breaks down market size by Type, by End User and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by End User and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by End User, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by End User, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by End User, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by End User, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Organ On Chip: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Organ On Chip Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 Market Segmentation by End User
1.3.1 Global Organ On Chip Market Size by End User, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Organ On Chip Revenue Estimates and Forecasts 2020-2031
2.2 Global Organ On Chip Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Organ On Chip Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Organ On Chip Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Brain-on-a-chip Market Size by Players
3.3.2 Liver-on-a-chip Market Size by Players
3.3.3 Kidney-on-a-chip Market Size by Players
3.3.4 Lung-on-a-chip Market Size by Players
3.3.5 Heart-on-a-chip Market Size by Players
3.3.6 Intestine-on-a-chip Market Size by Players
3.3.7 Vessel-on-a-chip Market Size by Players
3.3.8 Other Organs Market Size by Players
3.4 Global Organ On Chip Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Organ On Chip Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Organ On Chip Revenue by End User
5.1.1 Global Historical and Forecasted Revenue by End User (2020-2031)
5.1.2 Revenue Market Share by End User (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by End User
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Organ On Chip Market Size by Type (2020-2031)
6.4 North America Organ On Chip Market Size by End User (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Organ On Chip Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Organ On Chip Market Size by Type (2020-2031)
7.4 Europe Organ On Chip Market Size by End User (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Organ On Chip Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Organ On Chip Market Size by Type (2020-2031)
8.4 Asia-Pacific Organ On Chip Market Size by End User (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Organ On Chip Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Organ On Chip Market Size by Type (2020-2031)
9.4 Central and South America Organ On Chip Market Size by End User (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Organ On Chip Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Organ On Chip Market Size by Type (2020-2031)
10.4 Middle East and Africa Organ On Chip Market Size by End User (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Organ On Chip Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Emulate
11.1.1 Emulate Corporation Information
11.1.2 Emulate Business Overview
11.1.3 Emulate Organ On Chip Product Features and Attributes
11.1.4 Emulate Organ On Chip Revenue and Gross Margin (2020-2025)
11.1.5 Emulate Organ On Chip Revenue by Product in 2024
11.1.6 Emulate Organ On Chip Revenue by End User in 2024
11.1.7 Emulate Organ On Chip Revenue by Geographic Area in 2024
11.1.8 Emulate Organ On Chip SWOT Analysis
11.1.9 Emulate Recent Developments
11.2 Mimetas
11.2.1 Mimetas Corporation Information
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Organ On Chip Product Features and Attributes
11.2.4 Mimetas Organ On Chip Revenue and Gross Margin (2020-2025)
11.2.5 Mimetas Organ On Chip Revenue by Product in 2024
11.2.6 Mimetas Organ On Chip Revenue by End User in 2024
11.2.7 Mimetas Organ On Chip Revenue by Geographic Area in 2024
11.2.8 Mimetas Organ On Chip SWOT Analysis
11.2.9 Mimetas Recent Developments
11.3 TissUse
11.3.1 TissUse Corporation Information
11.3.2 TissUse Business Overview
11.3.3 TissUse Organ On Chip Product Features and Attributes
11.3.4 TissUse Organ On Chip Revenue and Gross Margin (2020-2025)
11.3.5 TissUse Organ On Chip Revenue by Product in 2024
11.3.6 TissUse Organ On Chip Revenue by End User in 2024
11.3.7 TissUse Organ On Chip Revenue by Geographic Area in 2024
11.3.8 TissUse Organ On Chip SWOT Analysis
11.3.9 TissUse Recent Developments
11.4 Valo Health
11.4.1 Valo Health Corporation Information
11.4.2 Valo Health Business Overview
11.4.3 Valo Health Organ On Chip Product Features and Attributes
11.4.4 Valo Health Organ On Chip Revenue and Gross Margin (2020-2025)
11.4.5 Valo Health Organ On Chip Revenue by Product in 2024
11.4.6 Valo Health Organ On Chip Revenue by End User in 2024
11.4.7 Valo Health Organ On Chip Revenue by Geographic Area in 2024
11.4.8 Valo Health Organ On Chip SWOT Analysis
11.4.9 Valo Health Recent Developments
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Corporation Information
11.5.2 CN Bio Innovations Business Overview
11.5.3 CN Bio Innovations Organ On Chip Product Features and Attributes
11.5.4 CN Bio Innovations Organ On Chip Revenue and Gross Margin (2020-2025)
11.5.5 CN Bio Innovations Organ On Chip Revenue by Product in 2024
11.5.6 CN Bio Innovations Organ On Chip Revenue by End User in 2024
11.5.7 CN Bio Innovations Organ On Chip Revenue by Geographic Area in 2024
11.5.8 CN Bio Innovations Organ On Chip SWOT Analysis
11.5.9 CN Bio Innovations Recent Developments
11.6 Hesperos
11.6.1 Hesperos Corporation Information
11.6.2 Hesperos Business Overview
11.6.3 Hesperos Organ On Chip Product Features and Attributes
11.6.4 Hesperos Organ On Chip Revenue and Gross Margin (2020-2025)
11.6.5 Hesperos Recent Developments
11.7 Draper Laboratory
11.7.1 Draper Laboratory Corporation Information
11.7.2 Draper Laboratory Business Overview
11.7.3 Draper Laboratory Organ On Chip Product Features and Attributes
11.7.4 Draper Laboratory Organ On Chip Revenue and Gross Margin (2020-2025)
11.7.5 Draper Laboratory Recent Developments
11.8 Nortis
11.8.1 Nortis Corporation Information
11.8.2 Nortis Business Overview
11.8.3 Nortis Organ On Chip Product Features and Attributes
11.8.4 Nortis Organ On Chip Revenue and Gross Margin (2020-2025)
11.8.5 Nortis Recent Developments
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Corporation Information
11.9.2 Micronit Microtechnologies B.V. Business Overview
11.9.3 Micronit Microtechnologies B.V. Organ On Chip Product Features and Attributes
11.9.4 Micronit Microtechnologies B.V. Organ On Chip Revenue and Gross Margin (2020-2025)
11.9.5 Micronit Microtechnologies B.V. Recent Developments
11.10 Kirkstall
11.10.1 Kirkstall Corporation Information
11.10.2 Kirkstall Business Overview
11.10.3 Kirkstall Organ On Chip Product Features and Attributes
11.10.4 Kirkstall Organ On Chip Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Corporation Information
11.11.2 Cherry Biotech SAS Business Overview
11.11.3 Cherry Biotech SAS Organ On Chip Product Features and Attributes
11.11.4 Cherry Biotech SAS Organ On Chip Revenue and Gross Margin (2020-2025)
11.11.5 Cherry Biotech SAS Recent Developments
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Corporation Information
11.12.2 Else Kooi Laboratory Business Overview
11.12.3 Else Kooi Laboratory Organ On Chip Product Features and Attributes
11.12.4 Else Kooi Laboratory Organ On Chip Revenue and Gross Margin (2020-2025)
11.12.5 Else Kooi Laboratory Recent Developments
11.13 Altis Biosystems
11.13.1 Altis Biosystems Corporation Information
11.13.2 Altis Biosystems Business Overview
11.13.3 Altis Biosystems Organ On Chip Product Features and Attributes
11.13.4 Altis Biosystems Organ On Chip Revenue and Gross Margin (2020-2025)
11.13.5 Altis Biosystems Recent Developments
11.14 Bi/ond
11.14.1 Bi/ond Corporation Information
11.14.2 Bi/ond Business Overview
11.14.3 Bi/ond Organ On Chip Product Features and Attributes
11.14.4 Bi/ond Organ On Chip Revenue and Gross Margin (2020-2025)
11.14.5 Bi/ond Recent Developments
11.15 Netri
11.15.1 Netri Corporation Information
11.15.2 Netri Business Overview
11.15.3 Netri Organ On Chip Product Features and Attributes
11.15.4 Netri Organ On Chip Revenue and Gross Margin (2020-2025)
11.15.5 Netri Recent Developments
11.16 Xona Microfluidics
11.16.1 Xona Microfluidics Corporation Information
11.16.2 Xona Microfluidics Business Overview
11.16.3 Xona Microfluidics Organ On Chip Product Features and Attributes
11.16.4 Xona Microfluidics Organ On Chip Revenue and Gross Margin (2020-2025)
11.16.5 Xona Microfluidics Recent Developments
11.17 SynVivo, Inc.
11.17.1 SynVivo, Inc. Corporation Information
11.17.2 SynVivo, Inc. Business Overview
11.17.3 SynVivo, Inc. Organ On Chip Product Features and Attributes
11.17.4 SynVivo, Inc. Organ On Chip Revenue and Gross Margin (2020-2025)
11.17.5 SynVivo, Inc. Recent Developments
11.18 Beijing Daxiang Biotech
11.18.1 Beijing Daxiang Biotech Corporation Information
11.18.2 Beijing Daxiang Biotech Business Overview
11.18.3 Beijing Daxiang Biotech Organ On Chip Product Features and Attributes
11.18.4 Beijing Daxiang Biotech Organ On Chip Revenue and Gross Margin (2020-2025)
11.18.5 Beijing Daxiang Biotech Recent Developments
11.19 AVATARGET
11.19.1 AVATARGET Corporation Information
11.19.2 AVATARGET Business Overview
11.19.3 AVATARGET Organ On Chip Product Features and Attributes
11.19.4 AVATARGET Organ On Chip Revenue and Gross Margin (2020-2025)
11.19.5 AVATARGET Recent Developments
11.20 Suzhou Jiyan Biopharmaceutical
11.20.1 Suzhou Jiyan Biopharmaceutical Corporation Information
11.20.2 Suzhou Jiyan Biopharmaceutical Business Overview
11.20.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Product Features and Attributes
11.20.4 Suzhou Jiyan Biopharmaceutical Organ On Chip Revenue and Gross Margin (2020-2025)
11.20.5 Suzhou Jiyan Biopharmaceutical Recent Developments
11.21 InSphero
11.21.1 InSphero Corporation Information
11.21.2 InSphero Business Overview
11.21.3 InSphero Organ On Chip Product Features and Attributes
11.21.4 InSphero Organ On Chip Revenue and Gross Margin (2020-2025)
11.21.5 InSphero Recent Developments
12 Organ On ChipIndustry Chain Analysis
12.1 Organ On Chip Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Organ On Chip Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Organ On Chip Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Organ On Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Organ On Chip Market Size Growth Rate by End User, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Organ On Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Organ On Chip Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Organ On Chip Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Organ On Chip Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Organ On Chip Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Organ On Chip by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ On Chip as of 2024)
Table 11. Global Organ On Chip Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Organ On Chip Companies Headquarters
Table 13. Global Organ On Chip Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Organ On Chip Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Organ On Chip Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Organ On Chip Revenue by End User (2020-2025) & (US$ Million)
Table 20. Global Organ On Chip Revenue by End User (2026-2031) & (US$ Million)
Table 21. Organ On Chip High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by End User
Table 24. North America Organ On Chip Growth Accelerators and Market Barriers
Table 25. North America Organ On Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Organ On Chip Growth Accelerators and Market Barriers
Table 27. Europe Organ On Chip Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Organ On Chip Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Organ On Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Organ On Chip Investment Opportunities and Key Challenges
Table 31. Central and South America Organ On Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Organ On Chip Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Organ On Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Emulate Corporation Information
Table 35. Emulate Description and Major Businesses
Table 36. Emulate Product Features and Attributes
Table 37. Emulate Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Emulate Revenue Proportion by Product in 2024
Table 39. Emulate Revenue Proportion by End User in 2024
Table 40. Emulate Revenue Proportion by Geographic Area in 2024
Table 41. Emulate Organ On Chip SWOT Analysis
Table 42. Emulate Recent Developments
Table 43. Mimetas Corporation Information
Table 44. Mimetas Description and Major Businesses
Table 45. Mimetas Product Features and Attributes
Table 46. Mimetas Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Mimetas Revenue Proportion by Product in 2024
Table 48. Mimetas Revenue Proportion by End User in 2024
Table 49. Mimetas Revenue Proportion by Geographic Area in 2024
Table 50. Mimetas Organ On Chip SWOT Analysis
Table 51. Mimetas Recent Developments
Table 52. TissUse Corporation Information
Table 53. TissUse Description and Major Businesses
Table 54. TissUse Product Features and Attributes
Table 55. TissUse Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. TissUse Revenue Proportion by Product in 2024
Table 57. TissUse Revenue Proportion by End User in 2024
Table 58. TissUse Revenue Proportion by Geographic Area in 2024
Table 59. TissUse Organ On Chip SWOT Analysis
Table 60. TissUse Recent Developments
Table 61. Valo Health Corporation Information
Table 62. Valo Health Description and Major Businesses
Table 63. Valo Health Product Features and Attributes
Table 64. Valo Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Valo Health Revenue Proportion by Product in 2024
Table 66. Valo Health Revenue Proportion by End User in 2024
Table 67. Valo Health Revenue Proportion by Geographic Area in 2024
Table 68. Valo Health Organ On Chip SWOT Analysis
Table 69. Valo Health Recent Developments
Table 70. CN Bio Innovations Corporation Information
Table 71. CN Bio Innovations Description and Major Businesses
Table 72. CN Bio Innovations Product Features and Attributes
Table 73. CN Bio Innovations Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. CN Bio Innovations Revenue Proportion by Product in 2024
Table 75. CN Bio Innovations Revenue Proportion by End User in 2024
Table 76. CN Bio Innovations Revenue Proportion by Geographic Area in 2024
Table 77. CN Bio Innovations Organ On Chip SWOT Analysis
Table 78. CN Bio Innovations Recent Developments
Table 79. Hesperos Corporation Information
Table 80. Hesperos Description and Major Businesses
Table 81. Hesperos Product Features and Attributes
Table 82. Hesperos Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Hesperos Recent Developments
Table 84. Draper Laboratory Corporation Information
Table 85. Draper Laboratory Description and Major Businesses
Table 86. Draper Laboratory Product Features and Attributes
Table 87. Draper Laboratory Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Draper Laboratory Recent Developments
Table 89. Nortis Corporation Information
Table 90. Nortis Description and Major Businesses
Table 91. Nortis Product Features and Attributes
Table 92. Nortis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Nortis Recent Developments
Table 94. Micronit Microtechnologies B.V. Corporation Information
Table 95. Micronit Microtechnologies B.V. Description and Major Businesses
Table 96. Micronit Microtechnologies B.V. Product Features and Attributes
Table 97. Micronit Microtechnologies B.V. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Micronit Microtechnologies B.V. Recent Developments
Table 99. Kirkstall Corporation Information
Table 100. Kirkstall Description and Major Businesses
Table 101. Kirkstall Product Features and Attributes
Table 102. Kirkstall Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Kirkstall Recent Developments
Table 104. Cherry Biotech SAS Corporation Information
Table 105. Cherry Biotech SAS Description and Major Businesses
Table 106. Cherry Biotech SAS Product Features and Attributes
Table 107. Cherry Biotech SAS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Cherry Biotech SAS Recent Developments
Table 109. Else Kooi Laboratory Corporation Information
Table 110. Else Kooi Laboratory Description and Major Businesses
Table 111. Else Kooi Laboratory Product Features and Attributes
Table 112. Else Kooi Laboratory Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Else Kooi Laboratory Recent Developments
Table 114. Altis Biosystems Corporation Information
Table 115. Altis Biosystems Description and Major Businesses
Table 116. Altis Biosystems Product Features and Attributes
Table 117. Altis Biosystems Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Altis Biosystems Recent Developments
Table 119. Bi/ond Corporation Information
Table 120. Bi/ond Description and Major Businesses
Table 121. Bi/ond Product Features and Attributes
Table 122. Bi/ond Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Bi/ond Recent Developments
Table 124. Netri Corporation Information
Table 125. Netri Description and Major Businesses
Table 126. Netri Product Features and Attributes
Table 127. Netri Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Netri Recent Developments
Table 129. Xona Microfluidics Corporation Information
Table 130. Xona Microfluidics Description and Major Businesses
Table 131. Xona Microfluidics Product Features and Attributes
Table 132. Xona Microfluidics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Xona Microfluidics Recent Developments
Table 134. SynVivo, Inc. Corporation Information
Table 135. SynVivo, Inc. Description and Major Businesses
Table 136. SynVivo, Inc. Product Features and Attributes
Table 137. SynVivo, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. SynVivo, Inc. Recent Developments
Table 139. Beijing Daxiang Biotech Corporation Information
Table 140. Beijing Daxiang Biotech Description and Major Businesses
Table 141. Beijing Daxiang Biotech Product Features and Attributes
Table 142. Beijing Daxiang Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Beijing Daxiang Biotech Recent Developments
Table 144. AVATARGET Corporation Information
Table 145. AVATARGET Description and Major Businesses
Table 146. AVATARGET Product Features and Attributes
Table 147. AVATARGET Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. AVATARGET Recent Developments
Table 149. Suzhou Jiyan Biopharmaceutical Corporation Information
Table 150. Suzhou Jiyan Biopharmaceutical Description and Major Businesses
Table 151. Suzhou Jiyan Biopharmaceutical Product Features and Attributes
Table 152. Suzhou Jiyan Biopharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Suzhou Jiyan Biopharmaceutical Recent Developments
Table 154. InSphero Corporation Information
Table 155. InSphero Description and Major Businesses
Table 156. InSphero Product Features and Attributes
Table 157. InSphero Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. InSphero Recent Developments
Table 159. Raw Materials Key Suppliers
Table 160. Distributors List
Table 161. Market Trends and Market Evolution
Table 162. Market Drivers and Opportunities
Table 163. Market Challenges, Risks, and Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ On Chip Product Picture
Figure 2. Global Organ On Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Brain-on-a-chip Product Picture
Figure 4. Liver-on-a-chip Product Picture
Figure 5. Kidney-on-a-chip Product Picture
Figure 6. Lung-on-a-chip Product Picture
Figure 7. Heart-on-a-chip Product Picture
Figure 8. Intestine-on-a-chip Product Picture
Figure 9. Vessel-on-a-chip Product Picture
Figure 10. Other Organs Product Picture
Figure 11. Global Organ On Chip Market Size Growth Rate by End User, 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Pharmaceutical & Biotechnology Companies
Figure 13. Academic & Research Institutes
Figure 14. Cosmetics Industry
Figure 15. Others
Figure 16. Organ On Chip Report Years Considered
Figure 17. Global Organ On Chip Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 19. Global Organ On Chip Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 20. Global Organ On Chip Revenue Market Share by Region (2020-2031)
Figure 21. Global Organ On Chip Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Brain-on-a-chip Revenue Market Share by Player in 2024
Figure 24. Liver-on-a-chip Revenue Market Share by Player in 2024
Figure 25. Kidney-on-a-chip Revenue Market Share by Player in 2024
Figure 26. Lung-on-a-chip Revenue Market Share by Player in 2024
Figure 27. Heart-on-a-chip Revenue Market Share by Player in 2024
Figure 28. Intestine-on-a-chip Revenue Market Share by Player in 2024
Figure 29. Vessel-on-a-chip Revenue Market Share by Player in 2024
Figure 30. Other Organs Revenue Market Share by Player in 2024
Figure 31. Global Organ On Chip Revenue Market Share by Type (2020-2031)
Figure 32. Global Organ On Chip Revenue Market Share by End User (2020-2031)
Figure 33. North America Organ On Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Players Organ On Chip Revenue (US$ Million) in 2024
Figure 35. North America Organ On Chip Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Organ On Chip Revenue (US$ Million) by End User (2020-2031)
Figure 37. US Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Organ On Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Players Organ On Chip Revenue (US$ Million) in 2024
Figure 42. Europe Organ On Chip Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Organ On Chip Revenue (US$ Million) by End User (2020-2031)
Figure 44. Germany Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 45. France Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Organ On Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Players Organ On Chip Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Organ On Chip Revenue (US$ Million) by Type (2020-2031)
Figure 52. Asia-Pacific Organ On Chip Revenue (US$ Million) by End User (2020-2031)
Figure 53. Indonesia Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 54. Japan Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 55. South Korea Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 56. Australia Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 57. India Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 58. Indonesia Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 59. Vietnam Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 60. Malaysia Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 61. Philippines Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 62. Singapore Organ On Chip Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Organ On Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Players Organ On Chip Revenue (US$ Million) in 2024
Figure 65. Central and South America Organ On Chip Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Organ On Chip Revenue (US$ Million) by End User (2020-2031)
Figure 67. Brazil Organ On Chip Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Organ On Chip Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East and Africa Organ On Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Players Organ On Chip Revenue (US$ Million) in 2024
Figure 71. South America Organ On Chip Revenue (US$ Million) by Type (2020-2031)
Figure 72. Middle East and Africa Organ On Chip Revenue (US$ Million) by End User (2020-2031)
Figure 73. GCC Countries Organ On Chip Revenue (2020-2025) & (US$ Million)
Figure 74. Israel Organ On Chip Revenue (2020-2025) & (US$ Million)
Figure 75. Egypt Organ On Chip Revenue (2020-2025) & (US$ Million)
Figure 76. South Africa Organ On Chip Revenue (2020-2025) & (US$ Million)
Figure 77. Organ On Chip Industry Chain Mapping
Figure 78. Channels of Distribution (Direct Vs Distribution)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Organ On Chip in 2031?
The global market size of Organ On Chip in 2031 was 1076 Million USD.
What is the annual compound growth rate of the global Organ On Chip market size from 2025 to 2031?
What was the global market size of Organ On Chip in 2025?
Which region is expected to have the highest market share?
Which companies rank high in the global Organ On Chip market?
Related Reports
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 174
USD 4900.00
(Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 141
USD 4250.00
(Single User License)
Global Organ On Chip Market Research Report 2026
The global Organ On Chip market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 1368 million by 2032, at a CAGR of 30.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 160
USD 2900.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Organ On Chip was estimated to be worth US$ 221 million in 2025 and is projected to reach US$ 1368 million, growing at a CAGR of 30.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 147
USD 3950.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-10-16
Pages: 152
USD 3950.00
(Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 115
USD 4250.00
(Single User License)
Global Organ On Chip Market Research Report 2025
The global market for Organ On Chip was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 1076 million by 2031, growing at a CAGR of 30.2% during the forecast period.
Published Date: 2025-09-08
Pages: 107
USD 2900.00
(Single User License)
Global Organ On Chip Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Organ On Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 127
USD 3950.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published Date: 2024-01-06
Pages: 131
USD 3950.00
(Single User License)
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 174
USD 4900.00 (Single User License)Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 141
USD 4250.00 (Single User License)Global Organ On Chip Market Research Report 2026
The global Organ On Chip market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 1368 million by 2032, at a CAGR of 30.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 160
USD 2900.00 (Single User License)Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Organ On Chip was estimated to be worth US$ 221 million in 2025 and is projected to reach US$ 1368 million, growing at a CAGR of 30.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 147
USD 3950.00 (Single User License)Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-10-16
Pages: 152
USD 3950.00 (Single User License)Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 115
USD 4250.00 (Single User License)Global Organ On Chip Market Research Report 2025
The global market for Organ On Chip was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 1076 million by 2031, growing at a CAGR of 30.2% during the forecast period.
Published: 2025-09-08
Pages: 107
USD 2900.00 (Single User License)Global Organ On Chip Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Organ On Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 127
USD 3950.00 (Single User License)Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published: 2024-01-06
Pages: 131
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now